Viewing Study NCT03164967


Ignite Creation Date: 2025-12-25 @ 12:38 AM
Ignite Modification Date: 2026-01-06 @ 10:32 PM
Study NCT ID: NCT03164967
Status: COMPLETED
Last Update Posted: 2023-02-01
First Post: 2017-01-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate Safety and Pharmacokinetics of BIVIGAMĀ® in Primary Immune Deficiency Subjects Aged 2 to 16
Sponsor: ADMA Biologics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module